Clinical Trials in Los Angeles

Showing 12001-12020 of 14,465 trials

Seprafilm in the Reduction of Incidence of Bowel Obstruction in General Surgery

NCT00130715

The purpose of the study is to evaluate the efficacy of Seprafilm in reducing the incidence of bowel obstruction and to evaluate the incidence of all serious adverse events (SAEs) associated with the use of Seprafilm occurring within 30 days postoperatively, and the incidence of abdominopelvic abscess within 6 months postoperatively.

Intestinal ObstructionDigestive System Surgical Procedures

Genzyme, a Sanofi CompanyStarted Jun 1998

Scottsdale, Arizona, United States • Los Angeles, California, United States • Los Angeles, California, United States +18 more locations

COMPLETEDPhase 3< 1 mile

Prevention of Contrast Renal Injury With Different Hydration Strategies

NCT01218828

Using a randomized controlled trial design, two hydration protocols for the prevention of contrast medium-induced nephropathy will be tested.

Contrast Medium-induced Nephropathy

Kaiser Permanente396 participantsStarted Oct 2010

Los Angeles, California, United States

Seprafilm in the Reduction of Incidence of Bowel Obstruction in General Surgery

Prevention of Contrast Renal Injury With Different Hydration Strategies

Find Trials by Condition in Los Angeles

Trial for Prevention of Contrast Nephropathy With Sodium Bicarbonate

Treatment of Non-Gestational Acute Uterine Bleeding: A Randomized Trial

Monetary Incentives and Intrinsic Motivation to Sustain Hypertension Control

Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body.

S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple Myeloma

S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia

A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)

Safety, Tolerability, and Pharmacokinetics of CAT-192 (Human Anti-TGF-Beta1 Monoclonal Antibody) in Patients With Early Stage Diffuse Systemic Sclerosis

Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 1 to Less Than 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown Origin

Protocol of the Combination of Bortezomib and Tipifarnib for Relapsed or Refractory Multiple Myeloma

NVA237 BID Versus Placebo Twelve-week Efficacy Study

A Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years

S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis

Study of Meloxicam Capsules to Treat Osteoarthritis Pain

Patient-Reported Outcomes in Adults With Congenital Heart Disease

A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea

Study of ILX651 in Patients With Hormone-Refractory Prostate Cancer Previously Treated With Docetaxel

Phase I/II Study of CAMPATH in Patients With Relapsing or Refractory Non-Hodgkin's Lymphoma